Skip to content
healthcare.dev

VITRAKVI

NDC 50419-393, LAROTRECTINIB, solution, concentrate, from Bayer HealthCare Pharmaceuticals Inc..

Product NDC
50419-393
Status
Listed
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Dosage form
SOLUTION, CONCENTRATE
Route
OROPHARYNGEAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211710
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50419-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAROTRECTINIB20 mg/mL

Pharmacologic classes

Kinase Inhibitor [EPC]; Tropomyosin Receptor Kinases Inhibitors [MoA]

Package NDCNDC-11Package
50419-393-03504190393032 BOTTLE in 1 CARTON (50419-393-03) / 50 mL in 1 BOTTLE (50419-393-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0c8ca614-58b2-4aa4-83d3-0387a8f782fd

Use it

Look up 50419-393 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50419-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50419-393. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.